We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8283:TSEPaltac Corporation Analysis

Data as of 2026-06-27 - not real-time

HK$0.27

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock is trading well under its short‑term moving average, with the 20‑day SMA sitting far above the current price. RSI has slipped into the low‑30s, indicating limited momentum. MACD shows a bearish crossover, with the line beneath the signal and a negative histogram. Volume has been on a downtrend, and 30‑day volatility is described as extreme. Beta is negative, suggesting the stock moves opposite to the market, while historical max drawdown exceeds a very large proportion. The price‑to‑book ratio is under 0.4, pointing to a deep discount to book value. However, operating margins are negative, cash flow is negative, and debt relative to equity is moderate.
These fundamentals signal a distressed business with limited earnings visibility, and the company does not pay a dividend, making dividend sustainability a non‑issue. The consumer‑cyclical auto sector is currently pressured, adding sector‑specific risk. Geographic exposure to Singapore and mainland China introduces regulatory and currency considerations. Liquidity appears constrained given the small market cap and falling trading volumes. Overall, the technical picture is bearish, the financial health is weak, and upside potential appears limited without a clear turnaround catalyst.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • price well below short‑term moving averages
  • negative cash flow and operating losses
  • extremely high recent volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • deep discount to book value provides a valuation floor
  • potential for restructuring or asset rationalisation
  • sector cyclicality may improve with macro recovery

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • ongoing financial distress limits upside
  • absence of dividend reduces income appeal
  • possible recovery if regulatory and market conditions stabilize

Key Metrics & Analysis

Financial Health

Revenue Growth1.30%
Profit Margin-22.82%
ROE-51.33%
ROA-8.15%
Debt/Equity51.33
P/B Ratio0.3
Op. Cash FlowHK$-5341000
Free Cash FlowHK$-3295625

Technical Analysis

TrendBearish
RSI37.4
SupportHK$0.22
ResistanceHK$0.54
MA 20HK$0.32
MA 50HK$0.43
MA 200HK$0.51
MACDBearish
VolumeDecreasing
Fear & Greed Index88.55

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta-0.38
Volatility191.98%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.